VA
TECH icon

Vident Advisory’s Bio-Techne TECH Stock Holding History

Vident Advisory’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,584
Closed -$699K – 1733
2025
Q2 		$699K Buy
13,584
+154
+1% +$7.74K 0.01% 879
2025
Q1 		$787K Buy
13,430
+2,719
+25% +$184K 0.01% 820
2024
Q4 		$772K Sell
10,711
-660
-6% -$48.5K 0.01% 751
2024
Q3 		$909K Sell
11,371
-716
-6% -$53.8K 0.02% 663
2024
Q2 		$866K Sell
12,087
-41
-0.3% -$3.02K 0.02% 642
2024
Q1 		$854K Buy
12,128
+3,343
+38% +$239K 0.02% 632
2023
Q4 		$678K Sell
8,785
-397
-4% -$26.1K 0.02% 674
2023
Q3 		$625K Buy
+9,182
New +$725K 0.02% 639

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vident Advisory's TECH Position: Q3 2025 in Review

Vident Advisory sold out of Bio-Techne (TECH) in Q3 2025, closing a stake of 13,584 shares — an estimated $699K sold.

Vident Advisory first reported a position in TECH in Q3 2023 and held it in 8 quarters. The position peaked at $909K in Q3 2024. 577 funds tracked by Wall St. Rank hold TECH as of Q3 2025.

  • Vident Advisory reported no remaining Bio-Techne position as of Q3 2025 after selling out during the quarter.
  • Vident Advisory sold 13,584 Bio-Techne shares in Q3 2025, an estimated $699K.
  • Vident Advisory first reported a position in Bio-Techne in Q3 2023 and held it in 8 quarters.
  • Vident Advisory's Bio-Techne position peaked at $909K in Q3 2024.
  • 577 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2025.

Based on Vident Advisory's 13F filing for Q3 2025, filed 14 Nov 2025.